AIOBIO
Seoul, South Korea · $5.8M raised
- Headquarters
- Seoul
- Business Model
- B2B
- Website
- aiobio.co.kr
- Total Funding
- $5.8M
- Last Round
- $2.0M Venture RoundJan 2019
- Rounds
- 2
About
AI-powered dental diagnostic platform using fluorescence biomarker imaging for early disease detection.
Summary
AIOBIO is a Biotech company based in Seoul, South Korea. It has raised $5.8M in total across 2 rounds, most recently a $2.0M Venture Round round in Jan 2019. Investors include KIP Global Pharma Private Equity Fund, IMM Investment and Korea Investment Partners.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2019
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.